GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » Cyclically Adjusted PB Ratio

Hindustan Bio Sciences (BOM:532041) Cyclically Adjusted PB Ratio : (As of May. 27, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Hindustan Bio Sciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Hindustan Bio Sciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hindustan Bio Sciences Cyclically Adjusted PB Ratio Chart

Hindustan Bio Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.39 0.67 1.04

Hindustan Bio Sciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 - 1.04 1.13 -

Competitive Comparison of Hindustan Bio Sciences's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hindustan Bio Sciences's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's Cyclically Adjusted PB Ratio falls into.



Hindustan Bio Sciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Hindustan Bio Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Hindustan Bio Sciences's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/152.9243*152.9243
=0.000

Current CPI (Dec. 2023) = 152.9243.

Hindustan Bio Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201312 0.000 91.425 0.000
201403 8.213 91.425 13.738
201406 0.000 94.103 0.000
201409 7.130 96.780 11.266
201412 0.000 96.780 0.000
201503 6.739 97.163 10.606
201506 0.000 99.841 0.000
201509 6.797 101.753 10.215
201512 0.000 102.901 0.000
201603 4.702 102.518 7.014
201606 0.000 105.961 0.000
201609 4.481 105.961 6.467
201612 0.000 105.196 0.000
201703 4.223 105.196 6.139
201706 0.000 107.109 0.000
201709 4.050 109.021 5.681
201712 0.000 109.404 0.000
201803 2.003 109.786 2.790
201806 0.000 111.317 0.000
201809 2.024 115.142 2.688
201812 0.000 115.142 0.000
201903 2.111 118.202 2.731
201906 0.000 120.880 0.000
201909 2.107 123.175 2.616
201912 0.000 126.235 0.000
202003 2.189 124.705 2.684
202006 0.000 127.000 0.000
202009 2.268 130.118 2.666
202012 0.000 130.889 0.000
202103 1.273 131.771 1.477
202106 0.000 134.084 0.000
202109 1.145 135.847 1.289
202112 0.000 138.161 0.000
202203 0.768 138.822 0.846
202206 0.000 142.347 0.000
202209 0.670 144.661 0.708
202212 0.000 145.763 0.000
202303 0.728 146.865 0.758
202309 0.674 151.492 0.680
202312 0.000 152.924 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hindustan Bio Sciences  (BOM:532041) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Hindustan Bio Sciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hindustan Bio Sciences (BOM:532041) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences (BOM:532041) Headlines

No Headlines